Prelude Therapeutics IncorporatedPrelude Therapeutics IncorporatedPrelude Therapeutics Incorporated

Prelude Therapeutics Incorporated

No trades
See on Supercharts

PRLD fundamentals

An in-depth look to Prelude Therapeutics Incorporated operating, investing, and financing activities

PRLD free cash flow for Q3 24 is -27.36 M USD. For 2023, PRLD free cash flow was -110.58 M USD and operating cash flow was -107.06 M USD.

Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth